OR WAIT null SECS
June 18, 2021
The therapy is a modified poliovirus vaccine that not only kills cancer cells but also can trigger long-term immune memory.
June 16, 2021
Chances of left ventricular ejection fraction almost disappeared when patient took the ACE-inhibitor lisinopril during treatment with trastuzumab/anthracycline, according to research presented at ASCO.
Immune-related AEs can occur one to two years after treatment, are more common in combination treatments, and can be difficult to manage.
May 25, 2021
About 2% to 3% of patients with nonsmall cell lung cancer have EGFR exon 20 insertion mutations targeted by newly approved Rybrevant.
April 21, 2021
Opdivo is the first FDA-approved immunotherapy for the first-line treatment of gastric cancer.
March 09, 2021
The decision by Roche comes shortly after AstraZeneca withdrew the bladder cancer indication for durvalumab (Imfinzi).
February 16, 2021
February 10, 2021
One of the new treatments available is a CAR-T cell therapy to treat relapsed or refractory large B-cell lymphoma.
January 27, 2021
FDA cleared cabozantinib (Cabometyx) for patients with advanced renal cell carcinoma as a first-line treatment in combination with nivolumab (Opdivo).
January 12, 2021
New treatment for metastatic HER2-positive breast cancer is called Margenza.
